Literature DB >> 28174025

Effects of liposome-based local suppression of nerve growth factor in the bladder on autonomic dysreflexia during urinary bladder distention in rats with spinal cord injury.

Katsumi Kadekawa1, Tsuyoshi Yoshizawa2, Naoki Wada2, Takahiro Shimizu2, Tsuyoshi Majima2, Pradeep Tyagi2, William C de Groat3, Kimio Sugaya4, Naoki Yoshimura5.   

Abstract

PURPOSE: To examine (1) whether spinal cord injury (SCI) time-dependently increases the severity of autonomic dysreflexia (AD) and expression levels of bladder nerve growth factor (NGF) protein, and (2) whether local suppression of NGF in the bladder improves SCI-induced AD in rats.
MATERIALS AND METHODS: SCI was produced by the transection of the T2/3 spinal cord in female Sprague-Dawley rats. At 4 or 8weeks after SCI, differences in the mean arterial blood pressure (ΔMAP) and heart rate (ΔMHR) during graded increases in intravesical pressure to 20, 40 and 60cm H2O from those before bladder distention and NGF protein levels in the bladder wall were evaluated in spinal intact and SCI rats under urethane anesthesia. Seven weeks after SCI liposome-NGF antisense conjugates were administered intravesically to the animals. At 1week after intravesical treatment (8weeks after SCI), ΔMAP and ΔMHR during bladder distention and bladder NGF protein expression were evaluated.
RESULTS: The ΔMAP and ΔMHR were increased in a graded manner in response to bladder distention at intravesical pressures of 20, 40 and 60cm H2O in SCI rats. These AD-like cardiovascular responses and NGF protein expression in the bladder mucosal and muscle layers were increased after SCI in a time-dependent manner. The liposome-NGF antisense treatment significantly reduced the NGF protein overexpression in the mucosal layer of SCI rat bladder and reduced ΔMAP and ΔMHR elicited by bladder distention.
CONCLUSIONS: These results indicate that the duration of the post-SCI recovery period affects the severity of AD induced by bladder distention as well as the level of bladder NGF protein, and that local suppression of NGF expression in the bladder reduces SCI-induced AD. Thus, Intravesical application of liposome-NGF antisense conjugates can be a new effective therapy for bladder distention-induced AD after SCI.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autonomic dysreflexia; Liposome NGF antisense; Rat; Spinal cord injury

Mesh:

Substances:

Year:  2017        PMID: 28174025      PMCID: PMC5565153          DOI: 10.1016/j.expneurol.2017.01.014

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  34 in total

1.  Effects of an alpha1A/D-adrenoceptor antagonist, naftopidil, and a phosphodiesterase type 5 inhibitor, tadalafil, on urinary bladder remodeling in rats with spinal cord injury.

Authors:  Katsumi Kadekawa; Tsuyoshi Majima; Naoki Kawamorita; Hiroki Okada; Tsuyoshi Yoshizawa; Kenichi Mori; Pradeep Tyagi; Kimio Sugaya; Naoki Yoshimura
Journal:  Neurourol Urodyn       Date:  2016-10-04       Impact factor: 2.696

2.  Bladder overactivity and hyperexcitability of bladder afferent neurons after intrathecal delivery of nerve growth factor in rats.

Authors:  Naoki Yoshimura; Nelson E Bennett; Yukio Hayashi; Teruyuki Ogawa; Osamu Nishizawa; Michael B Chancellor; William C de Groat; Satoshi Seki
Journal:  J Neurosci       Date:  2006-10-18       Impact factor: 6.167

3.  Liposome Based Intravesical Therapy Targeting Nerve Growth Factor Ameliorates Bladder Hypersensitivity in Rats with Experimental Colitis.

Authors:  Naoki Kawamorita; Satoru Yoshikawa; Mahendra Kashyap; Pradeep Tyagi; Yoichi Arai; Michael B Chancellor; Naoki Yoshimura
Journal:  J Urol       Date:  2016-01-11       Impact factor: 7.450

4.  Telemetric blood pressure monitoring in conscious rats before and after compression injury of spinal cord.

Authors:  D N Mayorov; M A Adams; A V Krassioukov
Journal:  J Neurotrauma       Date:  2001-07       Impact factor: 5.269

Review 5.  Plasticity in reflex pathways to the lower urinary tract following spinal cord injury.

Authors:  William C de Groat; Naoki Yoshimura
Journal:  Exp Neurol       Date:  2011-05-09       Impact factor: 5.330

6.  A model of neural cross-talk and irritation in the pelvis: implications for the overlap of chronic pelvic pain disorders.

Authors:  Michael A Pezzone; Ruomei Liang; Matthew O Fraser
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

7.  Neutralizing intraspinal nerve growth factor blocks autonomic dysreflexia caused by spinal cord injury.

Authors:  N R Krenz; S O Meakin; A V Krassioukov; L C Weaver
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

Review 8.  Recognition and effective management of autonomic dysreflexia in spinal cord injuries.

Authors:  Jay Khastgir; Marcus J Drake; Paul Abrams
Journal:  Expert Opin Pharmacother       Date:  2007-05       Impact factor: 3.889

9.  Intravesical liposome administration--a novel treatment for hyperactive bladder in the rat.

Authors:  Matthew O Fraser; Yao-Chi Chuang; Pradeep Tyagi; Teruhiko Yokoyama; Naoki Yoshimura; Leaf Huang; William C De Groat; Michael B Chancellor
Journal:  Urology       Date:  2003-03       Impact factor: 2.649

10.  Plasticity of TRPV1-Expressing Sensory Neurons Mediating Autonomic Dysreflexia Following Spinal Cord Injury.

Authors:  Leanne M Ramer; A Peter van Stolk; Jessica A Inskip; Matt S Ramer; Andrei V Krassioukov
Journal:  Front Physiol       Date:  2012-07-09       Impact factor: 4.566

View more
  4 in total

Review 1.  Recommendations for evaluation of bladder and bowel function in pre-clinical spinal cord injury research.

Authors:  Gregory M Holmes; Charles H Hubscher; Andrei Krassioukov; Lyn B Jakeman; Naomi Kleitman
Journal:  J Spinal Cord Med       Date:  2019-09-26       Impact factor: 1.985

2.  The effect of neutralization of nerve growth factor (NGF) on bladder and urethral dysfunction in mice with spinal cord injury.

Authors:  Naoki Wada; Takahiro Shimizu; Nobutaka Shimizu; William C de Groat; Anthony J Kanai; Pradeep Tyagi; Hidehiro Kakizaki; Naoki Yoshimura
Journal:  Neurourol Urodyn       Date:  2018-03-08       Impact factor: 2.696

3.  Therapeutic effects of nerve growth factor-targeting therapy on bladder overactivity in rats with prostatic inflammation.

Authors:  Taro Igarashi; Pradeep Tyagi; Shinsuke Mizoguchi; Tetsuichi Saito; Akira Furuta; Yasuyuki Suzuki; Shin Egawa; Zhou Wang; Naoki Yoshimura
Journal:  Prostate       Date:  2021-10-01       Impact factor: 4.104

Review 4.  Drug Targets in Neurotrophin Signaling in the Central and Peripheral Nervous System.

Authors:  Mahendra Pratap Kashyap; Callie Roberts; Mohammad Waseem; Pradeep Tyagi
Journal:  Mol Neurobiol       Date:  2018-01-25       Impact factor: 5.590

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.